查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612894

細胞冷凍介質市場：按類型、應用和最終用途分類 - 2025-2030 年全球預測

Cell Freezing Media Market by Type (Dimethyl Sulfoxide-based Media, Glycerol-Based Media, Serum-Free Media), Application (Biobanking, Cancer Research, Genetic Engineering & CRISPR Technology), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年細胞冷凍介質市場價值為1.8571億美元，預計到2024年將達到2.0166億美元，複合年成長率為8.71%，到2030年將達到3.3325億美元。

細胞冷凍介質是一種用於冷凍保存的專用溶液，透過保護細胞在冷凍和解凍過程中免受損​​傷，在維持細胞活力和功能方面發揮重要作用。細胞冷凍介質的需求源自於多種領域的應用，包括生物樣本庫、再生醫學、製藥和學術研究。其最終用途範圍廣泛，涵蓋專注於保存脆弱細胞株、幹細胞和其他生物材料的醫療設施、實驗室和生物技術公司。生物醫學研究投資的增加、再生醫學的進步以及對生技藥品的需求不斷成長推動了市場成長，這些都刺激了對創新保存方法的需求。生物技術研發基礎設施不斷擴大的新興市場以及開發環保、無血清配方的機會比比皆是，這些配方可以最大限度地減少污染和過敏反應的風險，同時促進永續性。關鍵的成長要素包括技術進步、對個人化醫療的日益關注以及對幹細胞療法不斷成長的需求，這些因素正在推動有效冷凍保存策略的採用。該市場面臨的挑戰包括先進冷凍介質的高成本以及與解凍後維持細胞活力相關的技術挑戰。此外，監管限制和嚴格的品管標準可能會阻礙市場的快速擴張。為了緩解這些挑戰，公司應專注於開發符合行業標準的經濟高效且高效的替代方案。創新領域包括增強冷凍保護劑配方以提高細胞回收率、整合自動化冷凍保存系統以及開發新型添加劑以改善更廣泛細胞類型的保存。策略性成長也應考慮與學術和研究機構合作，推動創新並投資於市場教育，以提高對先進冷凍保存解決方案的好處和應用的認知。總體而言，細胞冷凍介質市場代表著一個充滿活力的機會，但需要克服某些技術和成本障礙才能充分發揮其潛力。

主要市場統計
基準年[2023] 1.8571 億美元
預測年份 [2024] 20166萬美元
預測年份 [2030] 33325萬美元
複合年成長率（%） 8.71%

市場動態：揭示快速發展的細胞冷凍介質市場的關鍵市場洞察

供需的動態交互作用正在改變細胞冷凍培養基市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 對先進生物製藥的需求迅速成長以及生物銀行活動的相應成長
    • 增加對基於細胞培養的疫苗的投資
    • 生物製藥製造中對一次性技術的偏好日益成長
  • 市場限制因素
    • 與細胞生物學研究相關的高成本
  • 市場機會
    • 再生醫學的進步和對高品質冷凍保存技術的需求
    • 人工智慧、物聯網等先進技術在培養基超低溫保存的融合
  • 市場挑戰
    • 核准和使用細胞冷凍介質的嚴格監管要求

波特的五力：駕馭細胞冷凍培養基市場的策略工具

波特的五力框架是了解細胞冷凍介質市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解細胞冷凍介質市場的外部影響

外部宏觀環境因素在塑造細胞冷凍介質市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解細胞冷凍介質市場的競爭格局

對細胞冷凍介質市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位基質細胞冷凍介質市場供應商的績效評估

FPNV定位矩陣是評估細胞冷凍介質市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了細胞冷凍介質市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，細胞冷凍介質市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對先進生物製藥的需求不斷增加以及生物銀行活動的相應成長
      • 增加對細胞培養疫苗的投資
      • 生物製藥製造中對一次性技術的日益青睞
    • 抑制因素
      • 與細胞生物學研究相關的高成本
    • 機會
      • 再生醫學的進步和對高品質冷凍保存技術的需求
      • 人工智慧、物聯網等先進技術在培養基超低溫保存的融合
    • 任務
      • 核准和使用細胞冷凍介質的嚴格監管要求
  • 市場區隔分析
    • 類型：在複雜皮膚病的生物製藥配方中使用甘油基載體
    • 最終用途：製藥和生物技術公司擴大使用細胞冷凍介質進行藥物發現和開發
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章細胞冷凍介質市場：依類型

  • 二甲基亞碸介質
  • 甘油基培養基
  • 無血清培養基

第7章細胞冷凍介質市場：依應用

  • 生物銀行
  • 癌症研究
  • 基因工程和CRISPR技術
  • 醫藥研發
  • 再生醫學
  • 疫苗開發

第 8 章細胞冷凍介質市場：依最終用途分類

  • 製藥和生物技術公司
  • 調查機構

第9章美洲細胞冷凍培養基市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太細胞冷凍培養基市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲細胞冷凍培養基市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 賽多利斯完成對 Polyplus 的收購
    • Qkine 和 Sartorius 合作創建了用於分析高級細胞模型的完整工作流程解決方案
    • ExCell Bio 在烏拉圭開設新工廠
  • 戰略分析和建議

公司名單

  • Abcam Limited
  • AMSBIO, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BPS Bioscience, Inc.
  • Capricorn Scientific
  • Carl Roth GmbH+Co. KG
  • Celprogen Corporation
  • Charles River Laboratories
  • Elabscience Bionovation Inc.
  • ExCell Biotechnology Co., Ltd
  • Funakoshi Co., Ltd.
  • HiMedia Laboratories
  • Merck KGaA
  • NIPPON Genetics EUROPE GmbH
  • PAN-Biotech GmbH
  • PromoCell GmbH
  • Qiagen NV
  • Sartorius AG
  • STEMCELL Technologies
  • Thermo Fisher Scientific Inc.
  • WELGENE Inc.
Product Code: MRR-3F223D524794

The Cell Freezing Media Market was valued at USD 185.71 million in 2023, expected to reach USD 201.66 million in 2024, and is projected to grow at a CAGR of 8.71%, to USD 333.25 million by 2030.

Cell freezing media, a specialized solution used in cryopreservation, plays a critical role in preserving the viability and functionality of cells by protecting them from damage during the freezing and thawing processes. The necessity for cell freezing media stems from its application across various fields including biobanking, regenerative medicine, pharmaceuticals, and academic research. Its end-use scope is vast, encompassing medical facilities, research laboratories, and biotech firms focusing on storing delicate cell lines, stem cells, and other biological materials. Market growth is driven by increased investments in biomedical research, advancements in regenerative medicine, and the growing need for biologics, which are fueling demand for innovative preservation methods. Opportunities are abundant in emerging markets where biotechnology R&D infrastructure is being expanded, as well as in developing eco-friendly and serum-free formulations that minimize risk of contamination and allergic reactions while promoting sustainability. Key growth influencers include technological advancements, a rising focus on personalized medicine, and increasing demand for stem cell therapies, which promote the adoption of effective cryopreservation strategies. Limitations in the market include the high cost of advanced freezing media and the technical challenges associated with maintaining cell viability post-thawing. Moreover, regulatory constraints and stringent quality control standards may hinder rapid market expansion. To mitigate such challenges, companies should focus on developing cost-effective and efficient alternatives that conform to industry standards. Areas of innovation include enhancing cryoprotectant formulations for better cell recovery rates, integrating automated cryopreservation systems, and developing novel additives that improve preservation of a wider range of cell types. For strategic growth, businesses should also consider collaborations with academic and research institutions to drive innovation, as well as investing in market education to boost awareness about the benefits and applications of advanced cryopreservation solutions. Overall, the cell freezing media market exhibits dynamic opportunities, yet requires overcoming certain technical and cost barriers to fully realize its potential.

KEY MARKET STATISTICS
Base Year [2023] USD 185.71 million
Estimated Year [2024] USD 201.66 million
Forecast Year [2030] USD 333.25 million
CAGR (%) 8.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Freezing Media Market

The Cell Freezing Media Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • The surging demand for advanced biopharmaceuticals and the consequent growth in biobanking activities
    • Increasing investment in cell culture-based vaccines
    • Growing preference for single-use technologies in biopharmaceutical production
  • Market Restraints
    • High cost associated with cell biology research
  • Market Opportunities
    • Advancements in regenerative medicine and the need for high-quality cryopreservation techniques
    • Integration of advanced technologies such as AI and IoT in media cryopreservation
  • Market Challenges
    • Strict regulatory requirements for the approval and use of cell freezing media

Porter's Five Forces: A Strategic Tool for Navigating the Cell Freezing Media Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Freezing Media Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Freezing Media Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Freezing Media Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Freezing Media Market

A detailed market share analysis in the Cell Freezing Media Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Freezing Media Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Freezing Media Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Freezing Media Market

A strategic analysis of the Cell Freezing Media Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Freezing Media Market, highlighting leading vendors and their innovative profiles. These include Abcam Limited, AMSBIO, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BPS Bioscience, Inc., Capricorn Scientific, Carl Roth GmbH + Co. KG, Celprogen Corporation, Charles River Laboratories, Elabscience Bionovation Inc., ExCell Biotechnology Co., Ltd, Funakoshi Co., Ltd., HiMedia Laboratories, Merck KGaA, NIPPON Genetics EUROPE GmbH, PAN-Biotech GmbH, PromoCell GmbH, Qiagen NV, Sartorius AG, STEMCELL Technologies, Thermo Fisher Scientific Inc., and WELGENE Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Freezing Media Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Dimethyl Sulfoxide-based Media, Glycerol-Based Media, and Serum-Free Media.
  • Based on Application, market is studied across Biobanking, Cancer Research, Genetic Engineering & CRISPR Technology, Pharmaceutical Research & Development, Regenerative Medicine, and Vaccine Development.
  • Based on End-Use, market is studied across Pharmaceutical & Biotechnology Companies and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. The surging demand for advanced biopharmaceuticals and the consequent growth in biobanking activities
      • 5.1.1.2. Increasing investment in cell culture-based vaccines
      • 5.1.1.3. Growing preference for single-use technologies in biopharmaceutical production
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with cell biology research
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in regenerative medicine and the need for high-quality cryopreservation techniques
      • 5.1.3.2. Integration of advanced technologies such as AI and IoT in media cryopreservation
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory requirements for the approval and use of cell freezing media
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Utilization of Glycerol-based media in biopharmaceutical formulations to cater to sophisticated skin conditions
    • 5.2.2. End-Use: Increasing usage of cell freezing media in pharmaceuticals and biotechnology firms for novel drug discovery and development
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Freezing Media Market, by Type

  • 6.1. Introduction
  • 6.2. Dimethyl Sulfoxide-based Media
  • 6.3. Glycerol-Based Media
  • 6.4. Serum-Free Media

7. Cell Freezing Media Market, by Application

  • 7.1. Introduction
  • 7.2. Biobanking
  • 7.3. Cancer Research
  • 7.4. Genetic Engineering & CRISPR Technology
  • 7.5. Pharmaceutical Research & Development
  • 7.6. Regenerative Medicine
  • 7.7. Vaccine Development

8. Cell Freezing Media Market, by End-Use

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Research Institutes

9. Americas Cell Freezing Media Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Freezing Media Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Freezing Media Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Sartorius completes acquisition of Polyplus
    • 12.3.2. Qkine and Sartorius Partnership Delivers a Complete Workflow Solution for the Analysis of Advanced Cell Models
    • 12.3.3. ExCell Bio Launches a New Factory in Uruguay
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam Limited
  • 2. AMSBIO, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Bio-Techne Corporation
  • 5. BPS Bioscience, Inc.
  • 6. Capricorn Scientific
  • 7. Carl Roth GmbH + Co. KG
  • 8. Celprogen Corporation
  • 9. Charles River Laboratories
  • 10. Elabscience Bionovation Inc.
  • 11. ExCell Biotechnology Co., Ltd
  • 12. Funakoshi Co., Ltd.
  • 13. HiMedia Laboratories
  • 14. Merck KGaA
  • 15. NIPPON Genetics EUROPE GmbH
  • 16. PAN-Biotech GmbH
  • 17. PromoCell GmbH
  • 18. Qiagen NV
  • 19. Sartorius AG
  • 20. STEMCELL Technologies
  • 21. Thermo Fisher Scientific Inc.
  • 22. WELGENE Inc.

LIST OF FIGURES

  • FIGURE 1. CELL FREEZING MEDIA MARKET RESEARCH PROCESS
  • FIGURE 2. CELL FREEZING MEDIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL FREEZING MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CELL FREEZING MEDIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CELL FREEZING MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL FREEZING MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL FREEZING MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL FREEZING MEDIA MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY DIMETHYL SULFOXIDE-BASED MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY GLYCEROL-BASED MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY BIOBANKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY GENETIC ENGINEERING & CRISPR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY PHARMACEUTICAL RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. CELL FREEZING MEDIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. CELL FREEZING MEDIA MARKET, FPNV POSITIONING MATRIX, 2023